Champions Oncology, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2024 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q3 2024 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q4 2024 | 1 | $0.01 | $0.01 | $0.01 |
| Q1 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q2 2025 | 1 | $0.02 | $0.02 | $0.02 |
Champions Oncology, Inc. Earnings Date And Information
Champions Oncology, Inc. last posted its earnings results on Wednesday, September 11th, 2024. The company reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of $0.01941 by $0.09059. The company had revenue of 14.06 M for the quarter and had revenue of 50.16 M for the year. Champions Oncology, Inc. has generated $-1 earnings per share over the last year ($-0.54 diluted earnings per share) and currently has a price-to-earnings ratio of -16.73. Champions Oncology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, December 10th, 2024 based on prior year's report dates.
Champions Oncology, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/13/2024 | Q1 2025 | $0.10 | $13.23 M | $14.06 M | ||
| 07/19/2024 | Q4 2024 | -$0.01 | $14.00 M | |||
| 03/14/2024 | Q3 2024 | -$0.19 | $13.50 M | $12.02 M | ||
| 12/13/2023 | Q2 2024 | -$0.15 | $12.82 M | $11.57 M | ||
| 09/13/2023 | Q1 2024 | -$0.10 | -$0.19 | -0.09 | $13.10 M | $12.56 M |
| 07/24/2023 | Q4 2023 | -$0.12 | -$0.19 | -0.07 | $13.07 M | |
| 03/16/2023 | Q3 2023 | -$0.18 | $13.13 M | $12.77 M | ||
| 12/13/2022 | Q2 2023 | -$0.00 | -$0.00 | -0 | $13.79 M | $14.28 M |
| 09/12/2022 | Q1 2023 | -$0.02 | $13.46 M | $13.75 M | ||
| 07/22/2022 | Q4 2022 | -$0.03 | $12.88 M | |||
| 03/15/2022 | Q3 2022 | $0.03 | $0.06 | 0.04 | $13.03 M | $13.19 M |
| 12/13/2021 | Q2 2022 | $0.01 | $0.02 | 0.02 | $11.67 M | $11.79 M |
| 09/13/2021 | Q1 2022 | -$0.00 | -$0.01 | -0.01 | $11.13 M | $11.25 M |
| 07/26/2021 | Q4 2021 | -$0.04 | $10.57 M | |||
| 03/15/2021 | Q3 2021 | $0.07 | $10.14 M | $10.81 M | ||
| 12/14/2020 | Q2 2021 | $0.01 | $0.00 | -0.01 | $9.81 M | $10.12 M |
| 09/14/2020 | Q1 2021 | $0.02 | $0.01 | -0.01 | $8.88 M | $9.55 M |
| 07/28/2020 | Q4 2020 | -$0.17 | $8.75 M | |||
| 03/16/2020 | Q3 2020 | $0.03 | $9.01 M | $9.01 M | ||
| 12/16/2019 | Q2 2020 | $0.01 | $0.03 | 0.02 | $7.63 M | $7.63 M |
Champions Oncology, Inc. Earnings: Frequently Asked Questions
-
When is Champions Oncology, Inc.'s earnings date?
Champions Oncology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, December 10th, 2024 based off last year's report dates.
-
Did Champions Oncology, Inc. beat their earnings estimates last quarter?
In the previous quarter, Champions Oncology, Inc. (:CSBR) reported $0.11 earnings per share (EPS) to beat the analysts' consensus estimate of $0.01941 by $0.09059.
-
How can I listen to Champions Oncology, Inc.'s earnings conference call?
The conference call for Champions Oncology, Inc.'s latest earnings report can be listened to online.
-
How can I read Champions Oncology, Inc.'s conference call transcript?
The conference call transcript for Champions Oncology, Inc.'s latest earnings report can be read online.
-
How much revenue does Champions Oncology, Inc. generate each year?
Champions Oncology, Inc. (:CSBR) has a recorded annual revenue of $50.16 M.
-
How much profit does Champions Oncology, Inc. generate each year?
Champions Oncology, Inc. (:CSBR) has a recorded net income of $50.16 M. Champions Oncology, Inc. has generated $-0.54 earnings per share over the last four quarters.
-
What is Champions Oncology, Inc.'s price-to-earnings ratio?
Champions Oncology, Inc. (:CSBR) has a price-to-earnings ratio of -16.73 and price/earnings-to-growth ratio is -0.31.
